Hospital Expenditures and Utilization: The Impact of HMOsByGerard F. Anderson, PhD,Nannan Zhang, PhD,Chantal Worzala, MPAJuly 1st 1999
The Cost of Alzheimer's Disease in Managed Care: A Cross-Sectional StudyByJoel Leon, PhD,Peter Neumann, ScDJuly 1st 1999
Efficacy and Cost Effectiveness of Lansoprazole Versus Omeprazole in Maintenance Treatment of Symptomatic Gastroesophageal Reflux DiseaseByEva Vivian, PharmD,Anthony Morreale, PharmD, BCPS, MBA,Eric Boyce, PharmD,Kimberly Lowry, PharmD,Oscar Ereso, PharmD,Patricia Hlavin, MDJuly 1st 1999
Payor Cost Savings with Endometrial Ablation TherapyByRobert London, MD,Martin Holzman, MBA,Darrin Rubin, MBA,Brian Moffitt, BSJuly 1st 1999
The Food and Drug Administration and Atrial Defibrillation DevicesByLeway Chen, MD,Anne T. Keane, PA-C, JD,Nathan R. Every, MD, MPHJuly 1st 1999
Benign Prostatic Hyperplasia: New Concepts for the MillenniumByBurkhardt Zorn, MD,John J. Bauer, MD,Judd W. Moul, MDJuly 1st 1999
Breast Cancer Prevention: The Role of AntiestrogensBySusan E. Fugate, PharmD,Andrea S. Franks, PharmD, BCPSJuly 1st 1999
The Impact of HMOs on Hospital Use and Cost? A Matter of InterpretationByDarrell J. Gaskin, PhD,John Kralewski, PhDJuly 1st 1999
